Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

Margaret O’donnell ,Patricia Kropf,Daniel A Arber,Stephen A Strickland,Melanie Fiorella,Guido Marcucci,Amir T Fathi,Jessica K Altman,Camille N Abboud,Joseph O Moore,Ndiya Ogba,Daniel A Pollyea,Farhad Ravandi,Dale Bixby,Steven D Gore,Aric C Hall,Deniz Peker,Frederick R Appelbaum,James M Foran,William Blum,Paul J Shami,Lori J Maness,Eunice S Wang,Martin S Tallman,Steven Coutré ,Matthew J Wieduwilt ,Keith W Pratz ,Michael Martin ,Richard Stone ,Vijaya Raj Bhatt ,Rebecca L Olin ,Jeffrey E Lancet ,Marcos J.g De Lima ,Kristina M Gregory

doi:10.6004/jnccn.2017.0116

Abstract

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. This portion of the NCCN Guidelines for AML focuses on management and provides recommendations on the workup, diagnostic evaluation, and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.

Full Text